HCM
AGN.PRA

Highlander Capital Management’s Allergan plc AGN.PRA Stock Holding History

Highlander Capital Management’s Portfolio AGN.PRA Stock Details AGN.PRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-15
Closed -$11K – 798
2016
Q4 		$11K Hold
15
– – 0.01% 598
2016
Q3 		$12K Buy
+15
New +$13K 0.01% 598

Other funds holding AGN.PRA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $112B AUM 36.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return
LCM
Lakewood Capital Management New York $1.94B AUM 9.49% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Highlander Capital Management's AGN.PRA Position: Q1 2017 in Review

Highlander Capital Management sold out of Allergan plc (AGN.PRA) in Q1 2017, closing a stake of 15 shares — an estimated $11K sold.

Highlander Capital Management first reported a position in AGN.PRA in Q3 2016 and held it in 2 quarters. The position peaked at $12K in Q3 2016. 106 funds tracked by Wall St. Rank hold AGN.PRA as of Q1 2017.

  • Highlander Capital Management reported no remaining Allergan plc position as of Q1 2017 after selling out during the quarter.
  • Highlander Capital Management sold 15 Allergan plc shares in Q1 2017, an estimated $11K.
  • Highlander Capital Management first reported a position in Allergan plc in Q3 2016 and held it in 2 quarters.
  • Highlander Capital Management's Allergan plc position peaked at $12K in Q3 2016.
  • 106 funds tracked by Wall St. Rank held Allergan plc as of Q1 2017.

Based on Highlander Capital Management's 13F filing for Q1 2017, filed 15 May 2017.